| scholarly article | Q13442814 |
| P50 | author | Albert de la Chapelle | Q5618748 |
| Boris Pasche | Q90575334 | ||
| Stephan M. Tanner | Q114529751 | ||
| Ilene Comeras | Q117262587 | ||
| Sandya Liyanarachchi | Q43376214 | ||
| Heather Hampel | Q58190685 | ||
| P2093 | author name string | Qinghua Zeng | |
| Zhongyuan Li | |||
| Maureen Sadim | |||
| Laura Valle | |||
| Michael J Pennison | |||
| Hong-Tao Zhang | |||
| Tarsicio Serena-Acedo | |||
| P2860 | cites work | Small changes in expression affect predisposition to tumorigenesis | Q59115695 |
| TbetaR-I(6A) is a candidate tumor susceptibility allele | Q73229775 | ||
| A very private TGF-beta receptor embrace | Q80614706 | ||
| Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes | Q81305073 | ||
| TGF-beta and cancer | Q81484456 | ||
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X | Q24618839 | ||
| Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells | Q24656526 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| The consensus coding sequences of human breast and colorectal cancers | Q27861035 | ||
| TGFbeta signaling in growth control, cancer, and heritable disorders | Q28142605 | ||
| Reversible Smad-dependent signaling between tumor suppression and oncogenesis | Q28564212 | ||
| Population genomics of human gene expression | Q29614905 | ||
| Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer | Q29616379 | ||
| Genetic analysis of genome-wide variation in human gene expression | Q29617852 | ||
| Somatic acquisition and signaling of TGFBR1*6A in cancer | Q34456847 | ||
| The logic of TGFbeta signaling. | Q34522372 | ||
| Allelic variations in gene expression | Q35611266 | ||
| Genetic predisposition to colorectal cancer | Q35930688 | ||
| Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia | Q36287377 | ||
| A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2 | Q36690009 | ||
| TGF-beta signaling alterations and susceptibility to colorectal cancer | Q36871584 | ||
| Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. | Q43170770 | ||
| TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies | Q44765711 | ||
| Smad3 mutant mice develop metastatic colorectal cancer | Q45345236 | ||
| TGFBR1*6A may contribute to hereditary colorectal cancer | Q46463202 | ||
| Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. | Q47855086 | ||
| Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. | Q53589404 | ||
| Evidence of Linkage to Chromosome 9q22.33 in Colorectal Cancer Kindreds from the United Kingdom | Q56437189 | ||
| Lack of an Association between the TGFBR1*6A Variant and Colorectal Cancer Risk | Q57319833 | ||
| P433 | issue | 5894 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 1361-1365 | |
| P577 | publication date | 2008-08-14 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer | |
| P478 | volume | 321 |
| Q59806882 | A Genome-Wide Study of Allele-Specific Expression in Colorectal Cancer |
| Q35451799 | A comprehensively molecular haplotype-resolved genome of a European individual |
| Q89414359 | A genetic variant located in the miR-532-5p-binding site of TGFBR1 is associated with the colorectal cancer risk |
| Q40327374 | A low-frequency variant in SMAD7 modulates TGF-β signaling and confers risk for colorectal cancer in Chinese population. |
| Q30884171 | A robust approach to identifying tissue-specific gene expression regulatory variants using personalized human induced pluripotent stem cells |
| Q33979369 | A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22. |
| Q36815060 | A uniform survey of allele-specific binding and expression over 1000-Genomes-Project individuals |
| Q39365572 | APC and Smad7 link TGFβ type I receptors to the microtubule system to promote cell migration. |
| Q33630653 | Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer |
| Q42115276 | Allele-specific expression of APC in adenomatous polyposis families. |
| Q34180277 | Allele-specific expression of TGFBR1 in colon cancer patients |
| Q36937332 | Allele-specific expression of mutated in colorectal cancer (MCC) gene and alternative susceptibility to colorectal cancer in schizophrenia. |
| Q64059376 | Allelic Switching of , , and during Colorectal Cancer Tumorigenesis |
| Q34067581 | Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15 |
| Q42739172 | Allelic imbalance of the TGFβR1 is not a major contributor to the genetic predisposition to colorectal cancer |
| Q39730089 | Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC). |
| Q42371193 | Associations of TGFBR1 and TGFBR2 gene polymorphisms with the risk of hypospadias: a case-control study in a Chinese population |
| Q34420469 | Bayesian analysis of genetic interactions in case-control studies, with application to adiponectin genes and colorectal cancer risk |
| Q37736767 | Candidate gene association studies: successes and failures |
| Q93200207 | Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology |
| Q33947765 | Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium |
| Q33842871 | Comprehensive assessment of variation at the transforming growth factor beta type 1 receptor locus and colorectal cancer predisposition |
| Q33933663 | Constitutively decreased TGFBR1 allelic expression is a common finding in colorectal cancer and is associated with three TGFBR1 SNPs |
| Q37985996 | Debate about TGFBR1 and the susceptibility to colorectal cancer |
| Q33898712 | Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2. |
| Q36241935 | Development and progression of colorectal neoplasia |
| Q38195526 | Dissecting the causal genetic mechanisms of coronary heart disease |
| Q33575005 | Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci |
| Q36245609 | Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers |
| Q33627202 | Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast |
| Q50233622 | Familial Colorectal Cancer Type X. |
| Q37687212 | Gene-gene interactions in gastrointestinal cancer susceptibility |
| Q37549913 | Genetic predisposition to human disease: allele-specific expression and low-penetrance regulatory loci |
| Q37040950 | Genetic variations in stem cell-related genes and colorectal cancer prognosis |
| Q54462280 | Genetic variations in the TGFβ signaling pathway, smoking and risk of colorectal cancer in a Chinese population. |
| Q34576292 | Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia |
| Q64044984 | Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis |
| Q26823498 | High-throughput sequencing for biology and medicine |
| Q34327369 | Impact of BRCA1 and BRCA2 variants on splicing: clues from an allelic imbalance study |
| Q35634864 | Increased variance in germline allele-specific expression of APC associates with colorectal cancer. |
| Q41891043 | Infrequent detection of germline allele-specific expression of TGFBR1 in lymphoblasts and tissues of colon cancer patients |
| Q38020473 | Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer. |
| Q29417030 | Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk |
| Q35071116 | Linkage analysis in familial non-Lynch syndrome colorectal cancer families from Sweden |
| Q31169519 | Little evidence for association between the TGFBR1*6A variant and colorectal cancer: a family-based association study on non-syndromic family members from Australia and Spain. |
| Q42315796 | Loss of TGFβ signaling promotes colon cancer progression and tumor-associated inflammation. |
| Q37696701 | Masking epistasis between MYC and TGF-β pathways in antiangiogenesis-mediated colon cancer suppression |
| Q24612859 | Modulation of mismatch repair and genomic stability by miR-155 |
| Q34500806 | Molecular characterization of TGF-β type I receptor gene (Tgfbr1) in Chlamys farreri, and the association of allelic variants with growth traits |
| Q97519699 | Natural Selection on Exonic SNPs Shapes Allelic Expression Imbalance (AEI) Adaptability in Lung Cancer Progression |
| Q37478088 | New insights into the aetiology of colorectal cancer from genome-wide association studies |
| Q34627905 | No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations |
| Q91736498 | Nongenic cancer-risk SNPs affect oncogenes, tumour-suppressor genes, and immune function |
| Q33932561 | Patterns of basal signaling heterogeneity can distinguish cellular populations with different drug sensitivities |
| Q59336749 | Polymorphisms of , are associated with prognosis of gastric cancer in a Chinese population |
| Q60931600 | RNA sequencing reveals the expression profiles of circRNA and indicates that circDDX17 acts as a tumor suppressor in colorectal cancer |
| Q28586795 | RNA2DNAlign: nucleotide resolution allele asymmetries through quantitative assessment of RNA and DNA paired sequencing data |
| Q38518256 | Recognition of and recent issues in hereditary diffuse gastric cancer |
| Q55504770 | Reply: Allelic imbalance of TGFBR1 is not a major contributor to the genetic predisposition to colorectal cancer. |
| Q35751762 | SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers |
| Q33782791 | Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility |
| Q35167227 | Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing |
| Q30488363 | TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta |
| Q37687142 | TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis |
| Q37634488 | TGF-β: duality of function between tumor prevention and carcinogenesis. |
| Q33957710 | TGFBR1 and cancer susceptibility |
| Q37331368 | TGFBR1 haplotypes and risk of non-small-cell lung cancer |
| Q34146418 | TGFBR1 intralocus epistatic interaction as a risk factor for colorectal cancer. |
| Q36578568 | TGFBR1 signaling and breast cancer |
| Q37228468 | TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk |
| Q97867213 | TGFβ biology in cancer progression and immunotherapy |
| Q41696433 | Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. |
| Q39155151 | Targeting TGF-β Signaling for Therapeutic Gain |
| Q37157932 | Tgfbr1 haploinsufficiency is a potent modifier of colorectal cancer development |
| Q30906575 | The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study |
| Q33470715 | The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study. |
| Q36198186 | The biology of incipient, pre-invasive or intraepithelial neoplasia |
| Q39558389 | The role of microRNAs in cancer susceptibility |
| Q34424145 | The utility of Apc-mutant rats in modeling human colon cancer. |
| Q33712568 | Transforming growth factor beta (TGF-beta) and inflammation in cancer |
| Q37428739 | Transforming growth factor beta as a therapeutic target in systemic sclerosis |
| Q34519034 | Translating RNA sequencing into clinical diagnostics: opportunities and challenges. |
| Q33732433 | Tumor haplotype assembly algorithms for cancer genomics |
| Q52655047 | Two novel colorectal cancer risk loci in the region on chromosome 9q22.32. |
| Q43087851 | Update on molecular diagnosis of hereditary hemorrhagic telangiectasia |
| Q35566324 | Variants in the netrin-1 receptor UNC5C prevent apoptosis and increase risk of familial colorectal cancer |
| Q37187461 | Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease |
| Q30625155 | eQTL Mapping Using RNA-seq Data |
| Q64068516 | α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas |
Search more.